Effects of glutamine supplements and radiochemotherapy on systemic immune and gut barrier function in patients with advanced esophageal cancer

Annals of Surgery

Volumn 227, Issue 4, 1998, Pages 485-491

  Yoshida, Shogo ^a   Matsui, Masasuke ^a   Shirouzu, Yuichirou ^a   Fujita, Hiromasa ^a   Yamana, Hideaki ^a   Shirouzu, Kazuo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; DIET SUPPLEMENTATION; ESOPHAGUS CANCER; FEMALE; HUMAN; IMMUNOREGULATION; INTESTINE MUCOSA PERMEABILITY; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL MEMBRANE PERMEABILITY; CISPLATIN; COMBINED MODALITY THERAPY; DIETARY SUPPLEMENTS; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; GLUTAMINE; HUMANS; INDICATORS AND REAGENTS; INTESTINAL MUCOSA; INTESTINES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PHENOLSULFONPHTHALEIN; RADIATION-SENSITIZING AGENTS;

EID: 0031879722     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199804000-00006     Document Type: Article

References (39)

1. Fujita H, Kakegawa T, Yamana H, et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer: comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg 1995;222:654-662.
2. Ishida K, Iizuka T, Ando N, Ide H. Phase II study of chemoradiotherapy for advanced squamous cell carcinoma of the thoracic esophagus: nine Japanese institutions trial. Jpn J Clin Oncol 1996;26: 310-315.
3. Prasad N, Prasad R, Thornby J, et al. Lymphocyte replication in lung cancer patients undergoing radiotherapy. Oncology 1980;37;107-110.
4. Hadfield TL, Marcus S, Smart CR. The effect of anticancer therapy on peripheral blood T and B lymphocyte counts and function. J Surg Oncol 1979;11:217-225.
5. Windmueller HG, Spaeth AE. Uptake and metabolism of plasma glutamine by the small intestine. J Biol Chem 1974;249:5070-5079.
6. Newsholme EA, Newsholme P, Curi R, et al. A role for muscle in the immune system and its importance in surgery, trauma, sepsis, and burns. Nutrition 1988;4:261-268.
7. Maclenan PA, Brown RA, Rennie MJ. A positive relationship between protein synthetic rate and intracellular glutamine concentration in perfused rat skeletal muscle. Fed Biochem Soc 1987; 215:181-187.
8. Klimberg VS, Sallum RM, Kasper M, et al. Oral glutamine accelerates healing of the small intestine and improves outcome after whole abdominal radiation. Arch Surg 1990;125:1040-1045.
9. Yoshida S, Yamasaki K, Kaibara A, et al. Glutamine supplementation in septic rats. J Jpn Surg Soc 1992;94:1078-1084. (in Japanese with English abstract)
10. Kaibara A, Yoshida S, Yamasaki K, et al. Effect of glutamine and chemotherapy on protein metabolism in tumor bearing rats. J Surg Res 1994;57:143-149.
11. Rouse K, Nwokedi E, Woodiff JE, et al. Glutamine enhances selectivity of chemotherapy through changes in glutathione metabolism. Ann Surg 1995;221:420-426.
12. Ziegler TR, Young LS, Benfell K, et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation: a randomized, double blind, controlled study. Ann Int Med 1992;116:821-828.
13. Sasaki J, Koyama H, Yamaguchi T, et al. Oral phenolsulfonphthalein (PSP) absorption test: an assessment of gastrointestinal mucosal damage in vivo. Digestion & Absorption 1992;15:87-90 (in Japanese with English abstract).
14. Smith RJ, Wilmore DW. Glutamine nutrition and requirements. JPEN 1990;14:94S-99S.
15. Yoshida S, Ishibashi N, Noake T, et al. Glutamine and arginine metabolism in tumor bearing rats receiving total parenteral nutrition. Metabolism 1997;46:370-373.
16. Windmueller HG. Glutamine utilization by the small intestine. Adv Enzymol 1982;53:202-237.
17. Ardawi MSM. Glutamine metabolism in human peripheral lymphocytes. Metabolism 1988;37:99-103.
18. Newsholme P, Gordon S, Newsholme EA. Rates of utilization and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophages. Biochem J 1987;242:631-636.
19. Kovacevic Z, Morris HP. The role of glutamine in the oxidative metabolism of malignant cells. Cancer Res 1972;32:326-335.
20. Lacy J, Wilmore DW. Is glutamine a conditionally essential amino acid? Nutr Rev 1990;48:297-313.
21. Fox AD, Kripke SA, Berman JR, et al. Reduction of the severity of enterocolitis by glutamine supplemented enteral diets. Surg Forum 1987;191:465-472.
22. Hwang TL, O'Dwyer ST, Smith RJ, et al. Preservation of small bowel mucosa using glutamine-enriched total parenteral nutrition. Surg Forum 1987;38:56-58.
23. Alverdy JA, Aoys E, Weiss - Carrington P, Burke A. The effect of glutamine-enriched TPN on gut immune cellularity. J Surg Res 1992; 52:34-38.
24. Yoshida S, Leskiew MJ, Schluter MD, et al. Effect of total parenteral nutrition, systemic sepsis, and glutamine on gut mucosa in rats. Am J Physiol 1992;26: E368-E373.
25. Fox AD, Kripke SA, De Paula JA, et al. Effect of glutamine supplemented enteral diet on methotrexate-induced enterocolitis. JPEN 1988; 12:325-331.
26. Tremel H, Kienle B, Weilemann LS, et al. Glutamine dipeptide supplemented parenteral nutrition maintains intestinal function in the critically ill. Gastroenterology 1994;107:1595-1601.
27. Nakamura I, Takada S, Ohtsuka N, et al. An assessment of indomethacin-induced gastrointestinal mucosa damage in vivo: enhancement of urinary recovery after oral administration of phenosulfonphthalein in rats. J Pharm Pharmacol 1983;35:369-372.
28. Sasaki J, Koyama H, Yamaguchi T, et al. Oral phenolsulfonphthalein (PSP) absorption test: an assessment of gastrointestinal mucosal damage in vivo. Digenstion & Absorption 1993;1624-1627 (in Japanese with English abstract).
29. Ross D. Glutathione, free radicals and chemotherapeutic agents: mechanisms of free-radicals induced toxicity and glutathione-dependent protection. Pharmacol Ther 1988;37:231-249.
30. Welborne TC. Ammonia production and glutamine incorporation into glutathione in the functioning rat kidney. Can J Biochem 1979;57: 233-237.
31. Austgen TR, Dudrick PS, Sitten H, et al. The effects of glutamine enriched total parenteral nutrition on tumor growth and host tissues. Ann Surg 1992;215:107-113.
32. Yoshida S, Kaibara A, Yamasaki K, et al. Effect of glutamine supplementation on protein metabolism and glutathione in tumor-bearing rats. JPEN 1995;19:492-497.
33. McGhee JR, Mestecky J, Elson CO, Kiyono H. Regulation of IgA synthesis and immune response by T cells and interleukins. J Clin Immunol 1989;9: 175-179.
34. Stratton J, Byfield R, Small RC, et al. A comparison of the acute effects of radiation therapy, including or excluding thymus, on the lymphocyte sub-populations of cancer patients. J Clin Invest 1975;56: 88-97.
35. Jenkins VK, Olson MH, Ellis HN. In vitro methods of assessing lymphocyte transformation in patients undergoing radiotherapy for bronchogenic cancer. Tex Rep Biol Med 1973;31:19-28.
36. Maluish AE, Strong DM. Lymphocyte proliferation. In: Rose NR, ed. Manual of Clinical Laboratory Immunology. 3rd ed., Washington, D.C: American Society for Microbiology 1986:274-281.
37. Cota L, Engstrom P, Paul A. Nonsurgical management of esophageal cancer: report of study of combined radiotherapy and chemotherapy. J Clin Oncol 1987;5:1783-1790.
38. Keane TJ, Harwood AR, Elhakim T. et al. Radical radiation therapy with 5 fluorouracil infusion and mitomycin C for esophageal squamous carcinoma. Radiation Oncol 1985;4:205-210.
39. John M, Flam M, Wittlinger P, Mowry PA. Inoperable esophageal carcinoma: results of aggressive synchronous radiotherapy and chemotherapy: a pilot study. Am J Clin Oncol 1978;10:310-316.